Eliquis and Electrolyte imbalance - a phase IV clinical study of FDA data

Summary:

Electrolyte imbalance is reported as a side effect among people who take Eliquis (apixaban), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Pantoprazole, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Electrolyte imbalance when taking Eliquis. It is created by eHealthMe based on reports of 189,425 people who have side effects when taking Eliquis from the FDA, and is updated regularly.

What is Eliquis?

Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,864 Eliquis users. Check the latest studies of Eliquis.

What is Electrolyte imbalance?

Electrolyte imbalance is found to be associated with 1,083 drugs and 1,219 conditions by eHealthMe. Check the latest studies of Electrolyte imbalance.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

189,425 people reported to have side effects when taking Eliquis.
Among them, 115 people (0.06%) have Electrolyte imbalance.

Could Eliquis cause Electrolyte imbalance?

Among these 115 people:

How long have people been on Eliquis when they have Electrolyte imbalance? *

Click here to view more results

What is the gender of people who have Electrolyte imbalance when taking Eliquis? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Eliquis and have Electrolyte imbalance?

- Check whether Electrolyte imbalance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eliquis:

Eliquis (191,864 reports)

Electrolyte imbalance treatments and more:

Electrolyte imbalance (14,795 reports)

How severe was Electrolyte imbalance and when was it recovered:

Electrolyte imbalance in Eliquis

Expand to all the drugs that have ingredients of apixaban:

Electrolyte imbalance and drugs with ingredients of apixaban (228 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eliquis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrolyte imbalance:

Electrolyte imbalance (1,083 drugs)

Browse all the conditions that are associated with Electrolyte imbalance:

Electrolyte imbalance (1,219 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Eliquis) and Eliquis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.